Beam Therapeutics Inc. insiders: buys and sells · BEAM

Directors, officers and 10%+ shareholders must report every purchase and sale of their company's stock to the SEC within two business days. Transactions filed between 2026-10-01 and 2026-10-16. All filings on SEC EDGAR →

Bought: $0
Sold: $1,193,310
Buys: 0
Sells: 3

The 3 transactions

Date	Who	Role	Transaction	Shares	Price	Amount
2026-10-16	Evans John M.	CEO	sell	25.000	23,984	$599,595
2026-10-15	Evans John M.	CEO	sell	25.000	23,566	$589,150
2026-10-01	Cavanagh Bethany J	SVP, Finance and Treasurer	sell	187	24,41	$4,565

How to read these transactions

There are 3 filed transactions for Beam Therapeutics Inc. (BEAM) between 2026-10-01 and 2026-10-16. They were made by 2 different people. Open-market buys: 0, for $0. Sells: 3, for $1,193,310.

Each transaction comes from a Form 4, the filing the person submits to the SEC. In the table, each row is one transaction: the date, who made it and their role, whether it is a buy or a sell, the number of shares, the declared price per share and the total amount.

Open-market buys are the ones people watch most, because whoever makes them puts in their own money. Sells say less: they often respond to taxes, diversification or sale plans scheduled in advance. A single transaction does not say much either; what people look at is whether they repeat, from how many people and for what amount.

Other companies with insider trades

KE Holdings Inc. (BEKE) · BETA Technologies, Inc. (BETA) · Better Home & Finance Holding Co (BETR) · Bank First Corp (BFC) · BREAD FINANCIAL HOLDINGS, INC. (BFH) · Butterfly Network, Inc. (BFLY) · SAUL CENTERS, INC. (BFS) · Big Digital Energy, Inc. (BGDE)

Public SEC data (EDGAR), Form 4. Open-market buys and sells only: option exercises and stock received as pay are left out. This is not investment advice.

Follow them next to your own portfolio

In Arvenyx you see these portfolios, insider buys and your own portfolio, across all your brokers, in one place.

Create a free account